LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 87.86 | 770.25 | 6312 | 12543 | 0.5032 | 0.6863 | MN20160304_L02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 87.86 | 770.25 | 6827 | 12543 | 0.5443 | 0.7195 | MN20160304_L02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 3.21 | 770.25 | 953 | 904 | 1.0535 | 1.5035 | MN20160304_L02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 3.21 | 770.25 | 839 | 904 | 0.9275 | 0.4456 | MN20160304_L02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 5.44 | 770.25 | 1096 | 1012 | 1.0822 | 1.4429 | MN20160304_L02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 5.44 | 770.25 | 956 | 1012 | 0.9440 | 0.7283 | MN20160304_L02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 7.66 | 770.25 | 1199 | 1090 | 1.1000 | 1.4191 | MN20160304_L02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 7.66 | 770.25 | 1031 | 1090 | 0.9459 | 0.7897 | MN20160304_L02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 10.06 | 770.25 | 1308 | 1218 | 1.0735 | 1.2261 | MN20160304_L02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 10.06 | 770.25 | 1143 | 1218 | 0.9380 | 0.8157 | MN20160304_L02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 12.28 | 770.25 | 1427 | 1358 | 1.0507 | 1.1246 | MN20160304_L02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 12.28 | 770.25 | 1232 | 1358 | 0.9071 | 0.7754 | MN20160304_L02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 14.50 | 770.25 | 1511 | 1497 | 1.0092 | 1.0192 | MN20160304_L02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 14.50 | 770.25 | 1320 | 1497 | 0.8816 | 0.7537 | MN20160304_L02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 16.73 | 770.25 | 1580 | 1664 | 0.9492 | 0.9084 | MN20160304_L02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 16.73 | 770.25 | 1416 | 1664 | 0.8507 | 0.7293 | MN20160304_L02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 18.95 | 770.25 | 1647 | 1832 | 0.8988 | 0.8364 | MN20160304_L02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 18.95 | 770.25 | 1462 | 1832 | 0.7978 | 0.6695 | MN20160304_L02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 21.17 | 770.25 | 1742 | 2008 | 0.8674 | 0.8044 | MN20160304_L02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 21.17 | 770.25 | 1550 | 2008 | 0.7718 | 0.6583 | MN20160304_L02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 23.39 | 770.25 | 1836 | 2244 | 0.8180 | 0.7559 | MN20160304_L02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 23.39 | 770.25 | 1632 | 2244 | 0.7271 | 0.6268 | MN20160304_L02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 25.62 | 770.25 | 1955 | 2514 | 0.7774 | 0.7257 | MN20160304_L02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 25.62 | 770.25 | 1682 | 2514 | 0.6688 | 0.5802 | MN20160304_L02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 27.84 | 770.25 | 2083 | 2833 | 0.7350 | 0.6978 | MN20160304_L02 | C22 |